GR1501

· Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GR1501, covering 2024-09-25 to 2024-09-25. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy and Safety of GR1501 in Patients with Radiographic Axial Spondyloarthritis [Phase 3]